期刊文献+

腹水超滤浓缩回输治疗难治性腹水临床观察 被引量:1

Effect of reinfusion of concentrated ascites fluid on refractory ascites
原文传递
导出
摘要 目的观察腹水超滤浓缩回输治疗难治性腹水临床疗效。方法将43例肝硬化患者随机分为两组,对照组20例,给予卧床休息,限钠、水,输血浆、白蛋白,利尿,护肝和适当放腹水加输白蛋白等综合治疗。治疗组23例,仅给予基础护肝和配合腹水超滤浓缩回输仪,自体腹水浓缩后回输入腹腔。观察患者治疗前后症状、体征、体重、尿量、血浆蛋白、血钠、钾变化和平均住院日及住院费用情况。结果治疗组患者治疗后体重、尿量、白蛋白、血肌酐、血钠钾指标及平均住院日及住院费用优于对照组,差异有统计学意义(P<0.05)。结论腹水超滤浓缩回输治疗肝硬化腹水,疗效好、住院费用少,值得临床推广。 Objective To observe the clinical efficacy of ultrafiltration transfusion treatment of concentrated ascites for refractory ascites.Methods Forty-three patients with liver cirrhosis were randomly divided into two groups,20 cases in control group were given comprehensive treatment such as bed rest,restriction of salt and water,transmission of blood and albumin,diuretic,liver protection,and appropriate paracentesis plus lose albumin.Twenty-three cases in treatment group were given liver protection and reinfusion of concentrated ascites fluid to the abdominal cavity by ascites reinfusion instrument.The symptoms,signs,body weight,urine volume,plasma protein,serum sodium,serum potassium,the average length of hospital stay and hospital costs were observed.Results The body weight,urine output,serum albumin,serum creatinine,serum sodium,serum potassium and the average length of hospital stay and hospitalization costs were suporior than those in the control group,the differences were significant(P0.05).Conclusion The effect of ultrafiltration transfusion of concentrated ascites on liver cirrhosis is good,and with less hospitalization costs,worthy of promotion.
作者 李胜军
出处 《临床医学》 CAS 2012年第6期12-13,共2页 Clinical Medicine
关键词 腹水超滤浓缩回输 肝硬化 腹水 Ultrafiltration reinfusion of concentrated ascites Liver cirrhosis Ascites
  • 相关文献

参考文献5

二级参考文献16

  • 1陈德永.对腹水浓缩回输治疗顽固性肝腹水评价[J].传染病信息,1998,11(3):108-109. 被引量:19
  • 2曾欣,林勇,谢渭芬.肝硬化腹水的处理[J].中华消化杂志,2005,25(12):757-759. 被引量:57
  • 3朱凤兰,朱建新,宋素珍.腹水浓缩回输腹腔治疗肝硬化难治性腹水21例疗效观察[J].苏州大学学报(医学版),2006,26(5):842-843. 被引量:9
  • 4周红宇,周国华,陈叶青.超滤浓缩回输治疗肝硬化难治性腹水疗效观察[J].南华大学学报(医学版),2007,35(4):568-570. 被引量:9
  • 5Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club.Hepatology,2003,38:258-266.
  • 6Gines P,Cardenas A,Arroyo V,et al.Management of cirrhosis and ascites.N Engl J Med,2004,350:1646-1654.
  • 7Gadano A,Moreau R,Vachiery F,et al.Natriuretic response to the combination of atrial natriuretic peptide and terlipressin inpatients with cirrhosis and refractory ascites.J Hepatol,1997,26:1229-1234.
  • 8Costello-Boerrigter LC,Boerrigter G,Burnett JC Jr.Revisiting salt and water retention:new diuretics,aquaretics,and natriuretics.Med Clin NorthAm,2003,87:475-491.
  • 9Janicic N,Verbalis JG.Evaluation and management of hypoosmolality in hospitalized patients.Endocrinol Metab Clin North Am,2003,32:459-481,vii.
  • 10Serradeil-Le Gal C.An overview of SR121463,a selective nonpeptide vasopressin V(2) receptor antagonist.Cardiovasc Drug Rev,2001,19:201-214.

共引文献152

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部